4 patents
Utility
Methods and Compositions for Treating Lung Conditions
5 Oct 23
The present invention provides compositions comprising mesenchymal stem cells (MSCs) and/or exosomes derived therefrom, mesenchymal stem cells secreting neurotrophic factors (MSC-NTFs) and/or exosomes derived therefrom, and methods for their use in treating adverse lung conditions, such as Coronavirus-related acute respiratory distress syndrome (ARDS).
Chaim LEBOVITS, Revital ARICHA, Yossef LEVY, Ralph KERN, Haggai KASPI, Jonathan SEMO
Filed: 20 Jul 21
Utility
Methods of Generating Mesenchymal Stem Cells Which Secrete Neurotrophic Factors
4 Nov 21
A method of generating MSCs which secrete neurotrophic factors (NTFs) comprising incubating a population of undifferentiated mesenchymal stem cells (MSCs) in a differentiating medium comprising basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF), heregulin and cAMP.
Yael GOTHELF, Yosef LEVY, Alex BURSHTEIN
Filed: 14 Jul 21
Utility
Methods for Treating Amyotrophic Lateral Sclerosis (Als)
6 May 21
Described herein are mesenchymal stem cells and populations thereof, which can be used for treating neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) disease.
Revital ARICHA, Yael GOTHELF, Natalie ABRAMOV, Haggai KASPI
Filed: 13 Jul 17
Utility
Cell-type Specific Exosomes and Use Thereof
4 Feb 21
Provided herein are highly-characterized isolated exosomes, methods to produce such exosomes, and methods for the use of such exosomes in treating diseases such as neurodegenerative diseases.
Revital ARICHA, Haggai KASPI, Jonathan SEMO, Yael GOTHELF
Filed: 10 Apr 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first